Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
21
NCT02966301
Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2016
Completion: Jun 30, 2020